Piper Sandler & Co’s Bristol-Myers Squibb BMY Stock Holding History

Piper Sandler & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-88	Closed	-$4K	–	19
2019 Q1	$4K	Buy	+88	New	+$4.38K	﹤0.01%	11

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Piper Sandler & Co's BMY Position: Q2 2019 in Review

Piper Sandler & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 88 shares — an estimated $4K sold.

Piper Sandler & Co first reported a position in BMY in Q1 2019 and held it in 1 quarter. The position peaked at $4K in Q1 2019. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Piper Sandler & Co reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Piper Sandler & Co sold 88 Bristol-Myers Squibb shares in Q2 2019, an estimated $4K.
Piper Sandler & Co first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 1 quarter.
Piper Sandler & Co's Bristol-Myers Squibb position peaked at $4K in Q1 2019.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Piper Sandler & Co's 13F filing for Q2 2019, filed 14 Aug 2019.